House Democrats unveiled updated legislative text of H.R. 1425, the Patient Protection and Affordable Care Enhancement Act – a bill to bolster coverage rates in the Affordable Care Act (ACA) Exchanges and state Medicaid programs. The bill would be paid for by incorporating provisions from the House Democrats’ prescription drug plan (H.R. 3), which passed the House on December 12, 2019 (estimated to provide $456 billion in savings to offset the package). Neither of these two “message” bills are expected to be considered by the Republican-controlled Senate but will, no doubt, be touted by Democrats during the campaign season heading into the November 2020 elections.
The House Rules Committee is scheduled to discuss H.R. 1425 this Wednesday, June 24. A House floor vote on the bill is anticipated before the 4th of July Congressional recess – potentially even as early as this Thursday, June 25. A vote this Thursday would be timed to coincide with the deadline for the Department of Justice (DOJ) to file its opening brief with the Supreme Court in the Affordable Care Act (ACA) lawsuit.
A summary of the major provisions of the bill is attached.